1	Health-care	JJ	2	amod
2	companies	NNS	5	nsubj
3	should	MD	5	aux
4	get	VB	5	dep
5	healthier	RBR	0	root
6	in	IN	5	prep
7	the	DT	9	det
8	third	JJ	9	amod
9	quarter	NN	6	pobj
10	.	.	5	punct

1	Medical-supply	JJ	2	amod
2	houses	NNS	4	nsubjpass
3	are	VBP	4	auxpass
4	expected	VBN	30	ccomp
5	to	TO	6	aux
6	report	VB	4	xcomp
7	earnings	NNS	8	nn
8	increases	NNS	6	dobj
9	of	IN	8	prep
10	about	RB	11	quantmod
11	15	CD	12	num
12	%	NN	9	pobj
13	on	IN	12	prep
14	average	NN	13	pobj
15	for	IN	8	prep
16	the	DT	18	det
17	third	JJ	18	amod
18	quarter	NN	15	pobj
19	,	,	4	punct
20	despite	IN	4	prep
21	sales	NNS	22	nn
22	increases	NNS	20	pobj
23	of	IN	22	prep
24	less	JJR	25	mwe
25	than	IN	26	quantmod
26	10	CD	27	num
27	%	NN	23	pobj
28	,	,	30	punct
29	analysts	NNS	30	nsubj
30	say	VBP	0	root
31	.	.	30	punct

1	To	TO	2	aux
2	offset	VB	10	purpcl
3	sluggish	JJ	5	amod
4	sales	NNS	5	nn
5	growth	NN	2	dobj
6	,	,	10	punct
7	companies	NNS	10	nsubj
8	have	VBP	10	aux
9	been	VBN	10	aux
10	cutting	VBG	0	root
11	staff	NN	10	dobj
12	,	,	10	punct
13	mostly	RB	14	advmod
14	through	IN	10	prep
15	attrition	NN	14	pobj
16	,	,	10	punct
17	and	CC	10	cc
18	slowing	VBG	10	conj
19	the	DT	20	det
20	growth	NN	18	dobj
21	in	IN	20	prep
22	research	NN	25	nn
23	and	CC	22	cc
24	development	NN	22	conj
25	spending	NN	21	pobj
26	.	.	10	punct

1	Sales	NNS	2	nn
2	growth	NN	7	nsubjpass
3	in	IN	2	prep
4	the	DT	5	det
5	quarter	NN	3	pobj
6	was	VBD	7	auxpass
7	slowed	VBN	0	root
8	by	IN	7	prep
9	mounting	JJ	10	amod
10	pressure	NN	8	pobj
11	from	IN	10	prep
12	groups	NNS	11	pobj
13	of	IN	12	prep
14	buyers	NNS	13	pobj
15	,	,	12	punct
16	such	JJ	17	mwe
17	as	IN	12	prep
18	hospitals	NNS	17	pobj
19	,	,	10	punct
20	to	TO	21	aux
21	hold	VB	10	infmod
22	down	RP	21	prt
23	prices	NNS	21	dobj
24	.	.	7	punct

1	Suppliers	NNS	4	nsubjpass
2	were	VBD	4	auxpass
3	also	RB	4	advmod
4	hurt	VBN	0	root
5	by	IN	4	prep
6	the	DT	9	det
7	stronger	JJR	9	amod
8	U.S.	NNP	9	nn
9	dollar	NN	5	pobj
10	,	,	9	punct
11	which	WDT	12	nsubj
12	makes	VBZ	9	rcmod
13	sales	NNS	16	nsubj
14	abroad	RB	13	advmod
15	more	RBR	16	advmod
16	difficult	JJ	12	xcomp
17	.	.	4	punct

1	In	IN	7	prep
2	some	DT	3	det
3	cases	NNS	1	pobj
4	,	,	7	punct
5	competition	NN	7	nsubj
6	has	VBZ	7	aux
7	squeezed	VBN	0	root
8	margins	NNS	7	dobj
9	.	.	7	punct

1	Becton	NNP	10	nsubj
2	,	,	1	punct
3	Dickinson	NNP	1	conj
4	&	CC	1	cc
5	Co.	NNP	1	conj
6	,	,	10	punct
7	for	IN	10	prep
8	example	NN	7	pobj
9	,	,	10	punct
10	faces	VBZ	0	root
11	stiff	JJ	12	amod
12	competition	NN	10	dobj
13	from	IN	12	prep
14	a	DT	16	det
15	Japanese	JJ	16	amod
16	supplier	NN	13	pobj
17	in	IN	12	prep
18	the	DT	21	det
19	important	JJ	21	amod
20	syringe	NN	21	nn
21	market	NN	17	pobj
22	.	.	10	punct

1	The	DT	7	det
2	Franklin	NNP	3	nn
3	Lakes	NNP	7	dep
4	,	,	3	punct
5	N.J.	NNP	3	dep
6	,	,	3	punct
7	company	NN	9	nsubjpass
8	is	VBZ	9	auxpass
9	expected	VBN	32	ccomp
10	to	TO	11	aux
11	report	VB	9	xcomp
12	sales	JJ	13	amod
13	growth	NN	11	dobj
14	of	IN	13	prep
15	only	JJ	20	quantmod
16	5	CD	20	number
17	%	NN	20	dep
18	to	TO	20	dep
19	6	CD	20	number
20	%	NN	14	pobj
21	,	,	9	punct
22	but	CC	9	cc
23	should	MD	25	aux
24	still	RB	25	advmod
25	maintain	VB	9	conj
26	earnings	NNS	27	nn
27	growth	NN	25	dobj
28	of	IN	27	prep
29	10	CD	30	num
30	%	NN	28	pobj
31	,	,	32	punct
32	says	VBZ	0	root
33	Jerry	NNP	35	nn
34	E.	NNP	35	nn
35	Fuller	NNP	32	nsubj
36	,	,	35	punct
37	an	DT	38	det
38	analyst	NN	35	appos
39	with	IN	38	prep
40	Duff	NNP	43	nn
41	&	CC	40	cc
42	Phelps	NNP	40	conj
43	Inc	NNP	39	pobj
44	.	.	32	punct

1	Among	IN	13	ccomp
2	the	DT	3	det
3	first	JJ	1	pobj
4	of	IN	3	prep
5	the	DT	6	det
6	group	NN	4	pobj
7	to	TO	8	aux
8	post	VB	3	infmod
9	results	NNS	8	dobj
10	,	,	13	punct
11	Abbott	NNP	12	nn
12	Laboratories	NNP	13	nsubj
13	said	VBD	0	root
14	third-quarter	JJ	16	amod
15	net	JJ	16	amod
16	income	NN	17	nsubj
17	jumped	VBD	13	ccomp
18	14	CD	19	num
19	%	NN	17	dobj
20	to	TO	17	prep
21	$	$	20	pobj
22	196	CD	21	number
23	million	CD	21	number
24	,	,	21	punct
25	or	CC	21	cc
26	88	CD	27	num
27	cents	NNS	21	conj
28	a	DT	29	det
29	share	NN	27	npadvmod
30	,	,	17	punct
31	from	IN	17	prep
32	$	$	31	pobj
33	172	CD	32	number
34	million	CD	32	number
35	,	,	32	punct
36	or	CC	32	cc
37	76	CD	38	num
38	cents	NNS	32	conj
39	a	DT	40	det
40	share	NN	38	npadvmod
41	,	,	32	punct
42	a	DT	43	det
43	year	NN	44	npadvmod
44	earlier	RBR	31	advmod
45	.	.	13	punct

1	Sales	NNS	13	nsubj
2	for	IN	1	prep
3	the	DT	4	det
4	company	NN	2	pobj
5	,	,	4	punct
6	based	VBN	4	partmod
7	in	IN	6	prep
8	Abbott	NNP	9	nn
9	Park	NNP	7	pobj
10	,	,	9	punct
11	Ill.	NNP	9	appos
12	,	,	9	punct
13	rose	VBD	0	root
14	8.3	CD	15	num
15	%	NN	13	dobj
16	to	TO	13	prep
17	$	$	16	pobj
18	1.31	CD	17	number
19	billion	CD	17	number
20	from	IN	13	prep
21	$	$	20	pobj
22	1.21	CD	21	number
23	billion	CD	21	number
24	.	.	13	punct

1	Baxter	NNP	2	nn
2	International	NNP	3	nn
3	Inc.	NNP	5	nsubj
4	yesterday	NN	5	tmod
5	reported	VBD	0	root
6	net	JJ	7	nsubj
7	climbed	VBD	5	ccomp
8	20	CD	9	num
9	%	NN	7	dobj
10	in	IN	7	prep
11	the	DT	13	det
12	third	JJ	13	amod
13	period	NN	10	pobj
14	to	TO	7	prep
15	$	$	14	pobj
16	102	CD	15	number
17	million	CD	15	number
18	,	,	15	punct
19	or	CC	15	cc
20	34	CD	21	num
21	cents	NNS	15	conj
22	a	DT	23	det
23	share	NN	21	npadvmod
24	,	,	7	punct
25	from	IN	7	prep
26	$	$	25	pobj
27	85	CD	26	number
28	million	CD	26	number
29	,	,	26	punct
30	or	CC	26	cc
31	28	CD	32	num
32	cents	NNS	26	conj
33	a	DT	34	det
34	share	NN	32	npadvmod
35	,	,	26	punct
36	a	DT	37	det
37	year	NN	38	npadvmod
38	earlier	RBR	25	advmod
39	.	.	5	punct

1	Sales	NNS	9	nsubj
2	for	IN	1	prep
3	the	DT	8	det
4	Deerfield	NNP	8	dep
5	,	,	4	punct
6	Ill.	NNP	4	dep
7	,	,	4	punct
8	company	NN	2	pobj
9	rose	VBD	0	root
10	5.8	CD	11	num
11	%	NN	9	dobj
12	to	TO	9	prep
13	$	$	12	pobj
14	1.81	CD	13	number
15	billion	CD	13	number
16	from	IN	9	prep
17	$	$	16	pobj
18	1.71	CD	17	number
19	billion	CD	17	number
20	.	.	9	punct

1	But	CC	5	cc
2	not	RB	3	neg
3	every	DT	4	amod
4	company	NN	5	nsubj
5	expects	VBZ	0	root
6	to	TO	7	aux
7	report	VB	5	xcomp
8	increased	VBN	9	amod
9	earnings	NNS	7	dobj
10	.	.	5	punct

1	C.R.	NNP	2	nn
2	Bard	NNP	3	nn
3	Inc.	NNP	5	nsubj
4	yesterday	NN	5	tmod
5	said	VBD	0	root
6	third-quarter	JJ	7	amod
7	net	JJ	8	nsubj
8	plunged	VBD	5	ccomp
9	51	CD	10	num
10	%	NN	8	dobj
11	to	TO	8	prep
12	$	$	11	pobj
13	9.9	CD	12	number
14	million	CD	12	number
15	,	,	12	punct
16	or	CC	12	cc
17	18	CD	18	num
18	cents	NNS	12	conj
19	a	DT	20	det
20	share	NN	18	npadvmod
21	,	,	8	punct
22	from	IN	8	prep
23	$	$	22	pobj
24	20	CD	23	number
25	million	CD	23	number
26	,	,	23	punct
27	or	CC	23	cc
28	35	CD	29	num
29	cents	NNS	23	conj
30	a	DT	31	det
31	share	NN	29	npadvmod
32	,	,	23	punct
33	a	DT	34	det
34	year	NN	35	npadvmod
35	earlier	RBR	22	advmod
36	.	.	5	punct

1	Sales	NNS	2	nsubj
2	fell	VBD	0	root
3	1.2	CD	4	num
4	%	NN	2	dobj
5	to	TO	2	prep
6	$	$	5	pobj
7	190.1	CD	6	number
8	million	CD	6	number
9	from	IN	2	prep
10	$	$	9	pobj
11	192.5	CD	10	number
12	million	CD	10	number
13	.	.	2	punct

1	The	DT	7	det
2	Murray	NNP	3	nn
3	Hill	NNP	7	dep
4	,	,	3	punct
5	N.J.	NNP	3	dep
6	,	,	3	punct
7	company	NN	8	nsubj
8	said	VBD	0	root
9	full-year	JJ	10	amod
10	earnings	NNS	12	nsubj
11	may	MD	12	aux
12	be	VB	8	ccomp
13	off	JJ	12	advmod
14	33	CD	15	num
15	cents	NNS	13	dep
16	a	DT	17	det
17	share	NN	15	npadvmod
18	because	IN	21	mark
19	the	DT	20	det
20	company	NN	21	nsubj
21	removed	VBD	12	advcl
22	a	DT	23	det
23	catheter	NN	21	dobj
24	from	IN	21	prep
25	the	DT	26	det
26	market	NN	24	pobj
27	.	.	8	punct

1	In	IN	6	prep
2	1988	CD	1	pobj
3	,	,	6	punct
4	the	DT	5	det
5	company	NN	6	nsubj
6	earned	VBD	0	root
7	$	$	6	dobj
8	1.38	CD	7	num
9	a	DT	10	det
10	share	NN	7	npadvmod
11	.	.	6	punct

1	The	DT	5	det
2	Food	NNP	5	nn
3	and	CC	2	cc
4	Drug	NNP	2	conj
5	Administration	NNP	7	nsubj
6	had	VBD	7	aux
7	raised	VBN	0	root
8	questions	NNS	7	dobj
9	about	IN	8	prep
10	the	DT	11	det
11	device	NN	13	poss
12	's	POS	11	possessive
13	design	NN	9	pobj
14	.	.	7	punct

1	Some	DT	2	det
2	analysts	NNS	3	nsubj
3	add	VBP	0	root
4	that	IN	12	complm
5	third-party	JJ	6	amod
6	pressures	NNS	12	nsubj
7	to	TO	8	aux
8	reduce	VB	6	infmod
9	health	NN	10	nn
10	costs	NNS	8	dobj
11	will	MD	12	aux
12	continue	VB	3	ccomp
13	to	TO	14	aux
14	bedevil	VB	12	xcomp
15	companies	NNS	18	poss
16	'	POS	15	possessive
17	bottom	JJ	18	amod
18	lines	NNS	14	dobj
19	.	.	3	punct

1	Takeover	NN	2	nn
2	speculation	NN	15	nsubj
3	,	,	2	punct
4	which	WDT	7	nsubj
5	has	VBZ	7	aux
6	been	VBN	7	aux
7	buoying	VBG	2	rcmod
8	stocks	NNS	7	dobj
9	of	IN	8	prep
10	supply	NN	11	nn
11	houses	NNS	9	pobj
12	,	,	2	punct
13	may	MD	15	aux
14	also	RB	15	advmod
15	ease	VB	17	ccomp
16	,	,	17	punct
17	says	VBZ	0	root
18	Peter	NNP	19	nn
19	Sidoti	NNP	17	nsubj
20	,	,	19	punct
21	an	DT	22	det
22	analyst	NN	19	appos
23	with	IN	22	prep
24	Drexel	NNP	26	nn
25	Burnham	NNP	26	nn
26	Lambert	NNP	27	nn
27	Inc	NNP	23	pobj
28	.	.	17	punct

1	``	``	20	punct
2	As	IN	4	mark
3	that	DT	4	nsubj
4	wanes	VBZ	8	advcl
5	,	,	8	punct
6	you	PRP	8	nsubj
7	're	VBP	8	aux
8	going	VBG	20	ccomp
9	to	TO	10	aux
10	see	VB	8	xcomp
11	the	DT	12	det
12	stocks	NNS	14	nsubj
13	probably	RB	14	advmod
14	wane	VBP	10	ccomp
15	as	IN	14	advmod
16	well	RB	15	advmod
17	,	,	20	punct
18	''	''	20	punct
19	he	PRP	20	nsubj
20	says	VBZ	0	root
21	.	.	20	punct

1	Hospitals	NNS	2	nn
2	companies	NNS	7	nsubj
3	,	,	7	punct
4	meanwhile	RB	7	advmod
5	,	,	7	punct
6	are	VBP	7	aux
7	reporting	VBG	0	root
8	improved	VBN	9	amod
9	earnings	NNS	7	dobj
10	.	.	7	punct

1	Bolstered	VBN	18	partmod
2	by	IN	1	prep
3	strong	JJ	4	amod
4	performances	NNS	2	pobj
5	by	IN	4	prep
6	its	PRP$	8	poss
7	psychiatric	JJ	8	amod
8	hospitals	NNS	5	pobj
9	,	,	18	punct
10	National	NNP	12	nn
11	Medical	NNP	12	nn
12	Enterprises	NNP	13	nn
13	Inc.	NNP	18	nsubj
14	,	,	13	punct
15	Los	NNP	16	nn
16	Angeles	NNP	13	appos
17	,	,	13	punct
18	reported	VBD	0	root
19	net	JJ	20	amod
20	income	NN	18	dobj
21	of	IN	20	prep
22	$	$	21	pobj
23	50	CD	22	number
24	million	CD	22	number
25	,	,	22	punct
26	or	CC	22	cc
27	65	CD	28	num
28	cents	NNS	22	conj
29	a	DT	30	det
30	share	NN	28	npadvmod
31	,	,	20	punct
32	for	IN	20	prep
33	the	DT	35	det
34	first	JJ	35	amod
35	quarter	NN	32	pobj
36	ended	VBN	35	partmod
37	Aug.	NNP	36	tmod
38	31	CD	37	num
39	,	,	20	punct
40	up	RB	20	advmod
41	from	IN	40	prep
42	$	$	41	pobj
43	41	CD	42	number
44	million	CD	42	number
45	,	,	42	punct
46	or	CC	42	cc
47	56	CD	48	num
48	cents	NNS	42	conj
49	a	DT	50	det
50	share	NN	48	npadvmod
51	,	,	42	punct
52	a	DT	53	det
53	year	NN	54	npadvmod
54	earlier	RBR	41	advmod
55	.	.	18	punct

1	Humana	NNP	2	nn
2	Inc.	NNP	9	nsubj
3	,	,	2	punct
4	Louisville	NNP	2	appos
5	,	,	4	punct
6	Ky.	NNP	4	appos
7	,	,	2	punct
8	also	RB	9	advmod
9	reported	VBD	0	root
10	favorable	JJ	11	amod
11	results	NNS	9	dobj
12	,	,	11	punct
13	with	IN	11	prep
14	net	JJ	15	amod
15	income	NN	13	pobj
16	of	IN	15	prep
17	$	$	16	pobj
18	66.7	CD	17	number
19	million	CD	17	number
20	,	,	17	punct
21	or	CC	17	cc
22	66	CD	23	num
23	cents	NNS	17	conj
24	,	,	15	punct
25	in	IN	15	prep
26	the	DT	28	det
27	fourth	JJ	28	amod
28	quarter	NN	25	pobj
29	ended	VBN	28	partmod
30	Aug.	NNP	29	tmod
31	31	CD	30	num
32	,	,	15	punct
33	up	RB	15	advmod
34	from	IN	33	prep
35	$	$	34	pobj
36	58.2	CD	35	number
37	million	CD	35	number
38	,	,	35	punct
39	or	CC	35	cc
40	59	CD	41	num
41	cents	NNS	35	conj
42	,	,	35	punct
43	a	DT	44	det
44	year	NN	45	npadvmod
45	earlier	RBR	34	advmod
46	.	.	9	punct

1	Analysts	NNS	2	nsubj
2	say	VBP	0	root
3	the	DT	4	det
4	handful	NN	14	nsubj
5	of	IN	4	prep
6	hospital	NN	7	nn
7	companies	NNS	5	pobj
8	that	WDT	12	nsubjpass
9	are	VBP	12	auxpass
10	still	RB	12	advmod
11	publicly	RB	12	advmod
12	traded	VBN	4	rcmod
13	are	VBP	14	aux
14	benefiting	VBG	2	ccomp
15	from	IN	14	prep
16	several	JJ	17	amod
17	trends	NNS	15	pobj
18	.	.	2	punct

1	Most	RBS	2	advmod
2	important	JJ	8	ccomp
3	,	,	8	punct
4	hospital	NN	5	nn
5	admission	NN	6	nn
6	rates	NNS	8	nsubj
7	are	VBP	8	aux
8	stabilizing	VBG	0	root
9	after	IN	8	prep
10	several	JJ	11	amod
11	years	NNS	9	pobj
12	of	IN	11	prep
13	decline	NN	12	pobj
14	.	.	8	punct

1	Moreover	RB	5	advmod
2	,	,	5	punct
3	companies	NNS	5	nsubj
4	have	VBP	5	aux
5	sold	VBN	0	root
6	off	RP	5	prt
7	many	JJ	5	dobj
8	of	IN	7	prep
9	their	PRP$	13	poss
10	smaller	JJR	13	amod
11	,	,	13	punct
12	less-profitable	JJ	13	amod
13	hospitals	NNS	8	pobj
14	and	CC	5	cc
15	have	VBP	16	aux
16	completed	VBN	5	conj
17	painful	JJ	18	amod
18	restructurings	NNS	16	dobj
19	.	.	5	punct

1	Humana	NNP	3	poss
2	's	POS	1	possessive
3	revenues	NNS	10	nsubjpass
4	,	,	10	punct
5	for	IN	10	prep
6	example	NN	5	pobj
7	,	,	10	punct
8	are	VBP	10	aux
9	being	VBG	10	auxpass
10	boosted	VBN	0	root
11	by	IN	10	prep
12	large	JJ	13	amod
13	increases	NNS	11	pobj
14	in	IN	13	prep
15	enrollments	NNS	14	pobj
16	in	IN	15	prep
17	the	DT	18	det
18	company	NN	22	poss
19	's	POS	18	possessive
20	health	NN	21	nn
21	maintenance	NN	22	nn
22	organizations	NNS	16	pobj
23	.	.	10	punct

1	Says	VBZ	0	root
2	Todd	NNP	3	nn
3	Richter	NNP	1	nsubj
4	,	,	3	punct
5	an	DT	6	det
6	analyst	NN	3	appos
7	with	IN	6	prep
8	Dean	NNP	10	nn
9	Witter	NNP	10	nn
10	Reynolds	NNP	7	pobj
11	:	:	1	punct
12	``	``	1	punct
13	The	DT	14	det
14	shakeout	NN	21	nsubj
15	in	IN	14	prep
16	the	DT	19	det
17	publicly	RB	18	advmod
18	traded	VBN	19	amod
19	companies	NNS	15	pobj
20	is	VBZ	21	cop
21	over	RB	1	ccomp
22	.	.	1	punct


